Current clinical tools rely on known cardiovascular risk elements, but they often do not account for complex interactions ...

Interest in women's health benefits skyrocketed in recent years, which may continue in the current political environment, ...

Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification services, today announced the acquisition of Anaerobe Systems, Inc.

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

What’s next: The Senate Finance Committee has advanced the Kids Off Social Media Act, which would ban kids from social media ...

One of the biggest challenges in managing AAA and PAD is the unpredictability of disease progression. For instance, while some small AAAs remain stable for years, others rupture unexpectedly, leading ...

Mino was rescued in June from the Caloosahatchee River in Lee County at just 55 pounds. Mino came from SeaWorld Florida and ...

We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...

NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is headquartered in Santa Ana, ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss potential strategies that teams can implement to ensure clinical trials are more representative of the general population.

The PACK trial 1 was a parallel-arm cluster randomised trial, assigning 48 clinics to the intervention arm (a training ...